|
TIMELESS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.79619999990588E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.601200E-03 |
| Normal-vs-Stage2 |
2.464200E-02 |
| Normal-vs-Stage3 |
2.440200E-03 |
| Normal-vs-Stage4 |
4.242200E-02 |
| Stage1-vs-Stage2 |
6.656200E-01 |
| Stage1-vs-Stage3 |
7.489500E-02 |
| Stage1-vs-Stage4 |
9.435800E-01 |
| Stage2-vs-Stage3 |
2.154200E-01 |
| Stage2-vs-Stage4 |
8.044800E-01 |
| Stage3-vs-Stage4 |
1.717150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.40280000004989E-06 |
| Normal-vs-AfricanAmerican |
4.739500E-03 |
| Normal-vs-Asian |
2.831900E-02 |
| Caucasian-vs-AfricanAmerican |
1.447790E-01 |
| Caucasian-vs-Asian |
8.443400E-01 |
| AfricanAmerican-vs-Asian |
7.775800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.56709999999239E-05 |
| Normal-vs-Female |
3.05410000001061E-06 |
| Male-vs-Female |
3.785700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.661700E-02 |
| Normal-vs-Extreme_Weight |
1.805920E-02 |
| Normal-vs-Obese |
1.360880E-04 |
| Normal-vs-Extreme_Obese |
6.598000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.697400E-01 |
| Normal_Weight-vs-Obese |
2.455400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.848000E-01 |
| Extreme_Weight-vs-Obese |
4.448300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.145200E-01 |
| Obese-vs-Extreme_Obese |
1.400250E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.343900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.44540000002191E-06 |
| Normal-vs-Age(61-80Yrs) |
1.057720E-03 |
| Normal-vs-Age(81-100Yrs) |
3.181800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.478420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.840400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.126000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.458200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.958450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.981000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.75444999999108E-05 |
| Normal-VS-Type2 PRCC |
1.346420E-02 |
| Normal-VS-KIRP CIMP |
6.138200E-02 |
| Normal-VS-Unclassified PRCC |
9.770500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.566000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.615200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.915600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.665400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.005800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.517800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.501800E-02 |
| Normal-vs-N1 |
1.168100E-02 |
| Normal-vs-N2 |
2.370000E-01 |
| N0-vs-N1 |
4.445600E-02 |
| N0-vs-N2 |
3.471000E-01 |
| N1-vs-N2 |
8.972600E-01 |
|
|
